MARKET

CEMI

CEMI

Chembio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.84
+0.03
+0.44%
After Hours: 6.77 -0.07 -1.02% 19:22 04/03 EDT
OPEN
6.85
PREV CLOSE
6.81
HIGH
7.10
LOW
6.26
VOLUME
652.89K
TURNOVER
--
52 WEEK HIGH
8.00
52 WEEK LOW
2.250
MARKET CAP
121.30M
P/E (TTM)
-8.5106
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CEMI stock price target is 9.25 with a high estimate of 10.00 and a low estimate of 7.00.

EPS

CEMI News

More
  • Company News for Apr 2, 2020
  • Zacks · 2d ago
  • Mid-Afternoon Market Update: Dow Tumbles 800 Points; Chembio Diagnostics Shares Spike Higher
  • Benzinga · 3d ago
  • CRNC, APRN, ARNC and VVUS among midday movers
  • Seeking Alpha - Article · 3d ago
  • Mid-Day Market Update: ProPetro Slides After Q4 Results; InflaRx Shares Jump
  • Benzinga · 3d ago

Industry

Pharmaceuticals
-0.14%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About CEMI

Chembio Diagnostics, Inc. (Chembio), and its subsidiary, Chembio Diagnostic Systems, Inc., develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company's products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies, and a multiplex rapid test for the detection of HIV and Syphilis antibodies. The HIV 1/2 rapid tests employ in-licensed and lateral flow technologies that are used with all blood matrices as samples, and are manufactured in a standard cassette format, a dipstick format and a barrel format. Its HIV 1/2 rapid antibody detection test incorporates the Dual Path Platform (DPP) POCT technology. The DPP HIV 1/2 Assay detects antibodies to HIV 1 and 2 in oral fluid samples, as well as in all blood matrices. The Company's product pipeline includes a multiplex rapid test for earlier detection of HIV and a multiplex test that detects HIV and Syphilis specific antibodies.
More

Webull offers kinds of Chembio Diagnostics Inc stock information, including NASDAQ:CEMI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CEMI stock news, and many more online research tools to help you make informed decisions.